# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
https://www.sec.gov/Archives/edgar/data/1374339/000155837025011875/pmn-20250904xs3.htm
- SEC Filing
ProMIS Neurosciences (NASDAQ:PMN) reported quarterly losses of $(0.29) per share which missed the analyst consensus estimate of...
Presentation to highlight the Company's proprietary protein-misfolding platform, EpiSelectTM, used to develop PMN310Posters...
The Warrants have an exercise price of $1.25 per Warrant Share, are immediately exercisable and will expire five years from the...
Shares of Vicor Corporation (NASDAQ:VICR) rose sharply in pre-market trading after posting second-quarter results.